| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Dialysis |







Departments of * Medicine and
Epidemiology and Preventive Medicine, University of Maryland School of Medicine, and
Pharmaceutical Research Computing, University of Maryland School of Pharmacy, Baltimore, Maryland
Address correspondence to: Dr. Jeffrey C. Fink, Room N3W143, 22 S. Greene Street, University of Maryland Medical System, Baltimore, MD 21201. Phone: 410-328-5720; Fax: 410-328-5685; E-mail: jfink{at}medicine.umaryland.edu
Received for publication May 4, 2006. Accepted for publication December 5, 2006.
This study set out to determine whether there is a center effect on anemia management in hemodialysis patients. The US Renal Data System and Medicare standard analysis files were analyzed. Between-center variation and within-facility correlations in hematocrit values were examined in two separate data sets (years 2000 and 2001) and compared with simulated samples that were composed of random values that assumed no center effect. Mixed-effect models were used to adjust for multiple factors and quantify the within-facility correlation in hematocrit values. Expected hematocrit values were compared in patients who underwent dialysis at poor and superior performing facilities with fixed characteristics including epoetin
dosing. There was a wider center variation in hematocrit for the actual versus simulated data and a coefficient of variation of 4.1% for the former versus 1.7% for the latter, in both years. The within-facility correlation for hematocrit was 0.053 (95% confidence interval 0.050 to 0.056; P < 0.001) in 2000 with similar values in 2001 but no within-facility correlation in the simulated data. The impact of these findings was demonstrated with a difference in expected hematocrit for a patient who was treated with fixed-dosage epoetin
in the poorest versus best performing units (mean difference in expected hematocrit 3.06; 95% confidence interval 3.03 to 3.09; P < 0.001). Key attributes of a center effect on anemia management in hemodialysis have been identified. The presence of a center effect suggests that there are facility-specific processes that influence performance in dialysis anemia management and are independent of commonly titrated inputs, such as dosing of erythropoietic agents.
This article has been cited by other articles:
![]() |
K. E. Chan, R. A. Lafayette, A. S. Whittemore, M. A. Hlatky, and J. Moran Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2948 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Desai, R. Bolus, A. Nissenson, S. Bolus, M. D. Solomon, O. Khawar, M. Gitlin, J. Talley, and B. M. R. Spiegel Identifying Best Practices in Dialysis Care: Results of Cognitive Interviews and a National Survey of Dialysis Providers Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1066 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishani, C. A. Solid, E. D. Weinhandl, D. T. Gilbertson, R. N. Foley, and A. J. Collins Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1682 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishani, H. Guo, D. T. Gilbertson, J. Liu, S. Dunning, A. J. Collins, and R. N. Foley Time to target haemoglobin concentration (11 g/dl) risk of hospitalization and mortality among incident dialysis patients Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673